A drug utilisation study to assess the effectiveness of risk minimisation measures and describe the prescribing practices of Doreta SR and tramadol/paracetamol combinations in Europe (DUS Doreta SR and tramadol/paracetamol combination)

First published 06/07/2022

Last updated 30/01/2025

EU PAS number:

EUPAS47961

Study

Finalised

Documents

Study protocol

Initial protocol

KrKa Doreta SR DUS PASS protocol V3.0_17 January 2022

English (2.5 MB - PDF)View document

Updated protocol

2673514_ Krka Doreta SR DUS PASS protocol_V4_23 Feb-2023

First published: 22/02/2024

English (755.4 KB - PDF)View document

Study results

Study report

2673514__Krka_Doreta_SR_DUS_KKLR402019_Final_Report_V2.0_25012024.pdf

English (1.39 MB - PDF)View document

Other information

Secondary tabs